ClinicalTrials.Veeva

Menu

Assessment of the Effect of Tumor Thickness and Site on Level IV Cervical Lymph Nodes in Squamous Cell Carcinoma of the Tongue and Floor of the Mouth: A Case Series Study

Cairo University (CU) logo

Cairo University (CU)

Status

Enrolling

Conditions

Tongue Neoplasms

Treatments

Procedure: removal of primary tumor, neck dissection

Study type

Interventional

Funder types

Other

Identifiers

NCT06169605
Cairo uni PhD

Details and patient eligibility

About

Regarding oral cavity cancer, the high incidence of neck metastasis along with its impact on survival and prognosis are in favor of elective neck dissection. Moreover, occult metastases could develop at lower levels in the neck (levels IV-V) Regarding the tongue, the rate of skip (occult) metastasis involving unremoved level IV cervical lymph nodes in squamous cell carcinoma of the tongue ranges from 0 % - 11.4 %. However, no data is available or a correlation between the risk of level IV involvement and the affection of specific tongue subsites or a certain cutoff value of tumor thickness.

Enrollment

20 estimated patients

Sex

All

Ages

15 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with squamous cell carcinoma of the tongue and floor of the mouth.
  • Age group: from 15 to 60 years old
  • No sex predilection

Exclusion criteria

  • Patients with recurrent squamous cell carcinoma of the tongue and floor of the mouth.
  • Irradiated patients or those taking chemotherapy.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Patients with squamous cell carcinoma of the tongue and floor of the mouth
Experimental group
Description:
Intervention group
Treatment:
Procedure: removal of primary tumor, neck dissection

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed Shawky, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems